These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26656532)

  • 21. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 23. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments.
    Karahmet Sher E; Alebić M; Marković Boras M; Boškailo E; Karahmet Farhat E; Karahmet A; Pavlović B; Sher F; Lekić L
    Int J Pharm; 2024 Jul; 660():124345. PubMed ID: 38885775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
    Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
    Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines and immune protection of principal Mediterranean marine fish species.
    Miccoli A; Saraceni PR; Scapigliati G
    Fish Shellfish Immunol; 2019 Nov; 94():800-809. PubMed ID: 31580938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.
    Almeida A; Cunha A; Gomes NC; Alves E; Costa L; Faustino MA
    Mar Drugs; 2009 Jul; 7(3):268-313. PubMed ID: 19841715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles as protein and gene carriers to mucosal surfaces.
    de la Fuente M; Csaba N; Garcia-Fuentes M; Alonso MJ
    Nanomedicine (Lond); 2008 Dec; 3(6):845-57. PubMed ID: 19025458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
    Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
    Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Part 4. viruses, bacteria and fungi].
    Werkman PJ
    Tijdschr Diergeneeskd; 2007 Jul 15-Aug 1; 132(14-15):565-70. PubMed ID: 17715811
    [No Abstract]   [Full Text] [Related]  

  • 36. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage-based delivery systems: engineering, applications, and challenges in nanomedicines.
    Wang H; Yang Y; Xu Y; Chen Y; Zhang W; Liu T; Chen G; Wang K
    J Nanobiotechnology; 2024 Jun; 22(1):365. PubMed ID: 38918839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of antimicrobial agents in aquaculture.
    Park YH; Hwang SY; Hong MK; Kwon KH
    Rev Sci Tech; 2012 Apr; 31(1):189-97. PubMed ID: 22849275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
    Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
    J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing and Formulation of Nanocarriers for "Alzheimer's and Parkinson's" Early Detection and Therapy.
    Abujamai J; Satar R; Ansari SA
    CNS Neurol Disord Drug Targets; 2024; 23(10):1251-1262. PubMed ID: 38351689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.